Charles E Gaber1, Cary C Cotton2, Swathi Eluri2, Jennifer L Lund1, Timothy M Farrell3, Evan S Dellon2. 1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 2. Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Diseases and Biology, Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 3. Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
BACKGROUND: Achalasia is a rare esophageal motility disorder of uncertain etiology. While past studies have indicated that autoimmune conditions and viral infections may be associated with development of achalasia, these associations are yet to be examined in large, population-based studies. METHODS: A matched case-control study was performed using administrative claim data from the IBM MarketScan Commercial Claims and Encounters Database between 2000 and 2019. A history of selected autoimmune conditions and viral infections was assessed using past medical claims. Multivariable conditional logistic regression was used to account for the matched nature of the study design and further control for confounding by demographic and clinical characteristics when reporting adjusted odds ratios (aORs). KEY RESULTS: Among 6769 cases and 27,076 controls, presence of any of the autoimmune conditions studied was associated with increased odds of achalasia (aOR = 1.26, 95% CI: 1.11, 1.42). Scleroderma or systemic sclerosis (aOR = 8.13, 95% CI: 3.34, 19.80) and Addison's disease (aOR = 3.83, 95% CI: 1.83, 8.04) had the strongest associations with achalasia. Presence of any of the viral infections studied was also associated with an increased risk of achalasia (aOR = 1.58, 95% CI: 1.23, 2.01). Varicella zoster virus (aOR = 3.84, 95% CI: 1.94, 7.62) and human papillomavirus (aOR = 1.77, 95% CI: 1.15, 2.73) both had strong relationships with achalasia. CONCLUSIONS AND INFERENCES: These findings suggest that achalasia may have autoimmune and viral components contributing to its etiology. Future mechanistic studies could target specific diseases and agents highlighted by this research.
BACKGROUND: Achalasia is a rare esophageal motility disorder of uncertain etiology. While past studies have indicated that autoimmune conditions and viral infections may be associated with development of achalasia, these associations are yet to be examined in large, population-based studies. METHODS: A matched case-control study was performed using administrative claim data from the IBM MarketScan Commercial Claims and Encounters Database between 2000 and 2019. A history of selected autoimmune conditions and viral infections was assessed using past medical claims. Multivariable conditional logistic regression was used to account for the matched nature of the study design and further control for confounding by demographic and clinical characteristics when reporting adjusted odds ratios (aORs). KEY RESULTS: Among 6769 cases and 27,076 controls, presence of any of the autoimmune conditions studied was associated with increased odds of achalasia (aOR = 1.26, 95% CI: 1.11, 1.42). Scleroderma or systemic sclerosis (aOR = 8.13, 95% CI: 3.34, 19.80) and Addison's disease (aOR = 3.83, 95% CI: 1.83, 8.04) had the strongest associations with achalasia. Presence of any of the viral infections studied was also associated with an increased risk of achalasia (aOR = 1.58, 95% CI: 1.23, 2.01). Varicella zoster virus (aOR = 3.84, 95% CI: 1.94, 7.62) and human papillomavirus (aOR = 1.77, 95% CI: 1.15, 2.73) both had strong relationships with achalasia. CONCLUSIONS AND INFERENCES: These findings suggest that achalasia may have autoimmune and viral components contributing to its etiology. Future mechanistic studies could target specific diseases and agents highlighted by this research.
Authors: Dafna D Gladman; Tabitha N Kung; Fotios Siannis; Fawnda Pellett; Vernon T Farewell; Peter Lee Journal: J Rheumatol Date: 2005-08 Impact factor: 4.666
Authors: Jessica Becker; Stefan Niebisch; Arcangelo Ricchiuto; Eva J Schaich; Gavin Lehmann; Tobias Waltgenbach; Annette Schafft; Timo Hess; Frank Lenze; Marino Venerito; Robert Hüneburg; Philipp Lingohr; Hanno Matthaei; Stefan Seewald; Uwe Scheuermann; Nicole Kreuser; Lothar Veits; Mira M Wouters; Henning R Gockel; Hauke Lang; Michael Vieth; Michaela Müller; Alexander J Eckardt; Burkhard H A von Rahden; Michael Knapp; Guy E Boeckxstaens; Rolf Fimmers; Markus M Nöthen; Henning G Schulz; Ines Gockel; Johannes Schumacher Journal: Eur J Gastroenterol Hepatol Date: 2016-06 Impact factor: 2.566
Authors: Charles E Gaber; Swathi Eluri; Cary C Cotton; Paula D Strassle; Timothy M Farrell; Jennifer L Lund; Evan S Dellon Journal: Clin Gastroenterol Hepatol Date: 2021-02-27 Impact factor: 11.382
Authors: Rishi D Naik; Michael F Vaezi; Anne A Gershon; Tina Higginbotham; Jason J Chen; Elizabeth Flores; Mike Holzman; Dhyanesh Patel; Michael D Gershon Journal: Gastroenterology Date: 2021-04-29 Impact factor: 33.883